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Summary 
Mice with homologous disruption of the interferon 3' (IFN-3') gene on the C57BL/6 background 
were infected with Leishmania major and the immune response assessed. In contrast to wild-type 
or heterozygous knockout mice, deficient animals were unable to restrict growth of the parasite 
and suffered lethal infection over 6-8 wk.  Although wild-type and heterozygous littermates 
developed CD4 + cells that contained transcripts for IFN-3, and lymphotoxin, typical of T helper 
type 1  (Thl)  cells,  the knockout mice developed CD4 + cells  that  contained transcripts  for 
interleukin 4 (IL-4), IL-5, and IL-13, typical of Th2 cells. ELISPOT assays confirmed the reciprocal 
patterns of IFN-3~ or IL-4 production by T cells in similar frequencies in the respective groups 
of mice, and antibody analysis confirmed the presence of Th2-mediated isotype switching in 
the knockout mice. These data suggest that CD4 § T  cells that normally respond to antigens 
by differentiation to Thl cells default to the Th2 pathway in the absence of endogenous IFN-% 
M  urine Th clones are divided into Thl and Th2 subsets 
. based upon the types of cytokines produced (1). Thl 
cells produce IFN-% lymphotoxin, and IL-2, and mediate 
delayed-type hypersensitivity reactions, whereas Th2 cells pro- 
duce IL-4, -5, -6, -9, -10,  and -13,  and stimulate antibody 
production. Reciprocal regulation occurs between these two 
subsets:  IFN-7 restricts the proliferation of Th2 clones and 
IL-4 and IL-10 interfere with IFN~ production by Thl clones. 
Studies using limiting dilution analysis (2) and transgenic mice 
(3, 4) suggest that individual naive T cells have the capacity 
to differentiate into either Thl and Th2 cells,  and intense 
interest has focused on the role of distinct cytokines in medi- 
ating the development of these effector subsets. 
Experimental leishmaniasis due to Leishmania major com- 
prises a well-characterized model for examining the develop- 
mental regulation of Thl and Th2 cell differentiation in vivo 
(5). Thl cells are required for protection and differentiate nat- 
urally in genetically resistant strains of mice, such as C57BL/6, 
whereas Th2 cells are nonprotective and differentiate natu- 
rally in genetically susceptible strains of mice, such as BALB/c. 
Prior studies using mice made deficient in IL-4 through gene 
disruption have documented the abrogation of Th2 responses 
in such animals after challenge with helminths, potent stimuli 
for Th2-biased reactions (6).  We used genetically resistant 
mice with homologous disruption of the IFN-3~ gene to assess 
whether such mice develop programmed Thl responses when 
challenged with L.  major, or whether CD4 + effector cells 
default into the Th2 pathway in the absence of endogenous 
IFN-7. 
Materials and Methods 
Animals and Parasites.  Mice with targeted disruption  of the 
IFN~ gene (IFN-',/~176  were developed and screened as described 
(7), backcrossed  seven  generations  onto the CD57BL/6 background, 
and maintained in the University of California at San Francisco 
(UCSF) Transgenic  Facility. 6-8-wk-old BALB/c  and C57BL/6 mice 
were obtained from The Jackson Laboratory (Bar Harbor, ME) and 
housed in the UCSF animal facility. Groups of five to six mice 
were  infected in  the hind  footpads  with  106  stationary-phase 
promastigotes of  L. major  (strain WHOM/IR/-/173) and the course 
of infection monitored as described (5). Designated BALB/c mice 
were treated intraperitoneally with I mg of anti-IL-4 mAb 11Bll 
at the time of inoculation of the parasites in order to induce a healer 
phenotype as described (8). 
Collection of LN Tissues.  For analysis of cytokine transcripts, 
the popliteal LN were collected at designated times and flash frozen 
in liquid nitrogen,  pulverized to a fine powder, and placed in 
RNAzol (Biotecx, Houston, TX).  For analysis of cell subsets, 
popliteal LN were excised, teased to a single-cell suspension, and 
incubated with mAb against CD4 + (GK1.5; Becton Dickinson & 
Co., Mountain View, CA). Cells were selected in a magnetic field 
using secondary antibody coupled to ferrous beads (Advanced  Mag- 
netics, Inc., Cambridge, MA) as described (9). Isolations were car- 
ried out entirely at 4~  The purity of the selected CD4 + popu- 
lation  exceeded 90%  as  assessed by  FACS  @ analysis (Becton 
Dickinson & Co.) in select experiments. Selection by this method 
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cyte populations. Single-cell  suspensions  from the popliteal  LN were 
used for the ELISPOT assays without further modification. 
Competitive RT-PCR.  Total  RNA was extracted in RNAzol ac- 
cording to the manufacturer's  directions. Reverse transcription was 
performed using murine Moloney leukemia  virus reverse transcrip- 
tase (GIBCO BILL,  Bethesda, MD) and random hexamer primers 
(Promega, Madison, WI) as described (10). PCR was performed 
using a multiple cytokine-containing competitor construct as de- 
scribed in detail elsewhere (10). Briefly, aliquots of cDNA were 
assayed for levels of the constitutively expressed mRNA, hypo- 
xanthine-guanine phosphoribosyltransferase  (HPRT), by placing 
equal concentrations of the competitor construct in each reaction 
and examining the ratio of competitor to the wild-type band in- 
tensity after amplification  using HPRT-specific  primers. After sepa- 
ration on a 2.5% ethidium bromide-stained agarose gel, this vi- 
sual inspection can discern differences as small as 1.25-fold (10). 
After adjusting the amount of  experimental  cDNA in order to stan- 
dardize the HPRT levels to comparable  intensities relative to a con- 
stant competitor concentration,  cytokine  transcript  levels were quan- 
titated using the competitor in the presence of cytokine-specific 
primers. The primers used for HPRT, II.,4, IL-5, and IFN-3, were 
as described  (10). Additional  primers included  those for lymphotoxin 
(  5  '-ATGACACTGCTCGGCCGTCTCCA;  3~  - 
GGATCAGGAGGGAG; [11]) and Ib13  (5'-CTTGCTTGCCTT- 
GGTGGTCTCGC,  Y -GCAGTTT  TGTTATAAAGTGGGCT; 
[12]). All analyses  were repeated in three independent experiments. 
HPRT levels were reestablished at the end of each experiment to 
confirm their reproducibility. Photographic negatives of the gels 
were scanned with an imaging densitometer (BioRad Laborato- 
ries, Inc., Hercules, CA) in order to quantitate band intensities. 
ELISPOT Assays.  Cytokine production by individual  lympho- 
cytes was assessed by a modification of described methods (13). 
Single-cell suspensions were prepared from popliteal LN and dis- 
tributed in duplicate aliquots containing 106 cells in 100/zl RPMI 
with 5% fetal bovine serum (FBS) and antibiotics to 96-well plates 
(Immulon II; Dynatech, Chantilly, VA) that had been precoated 
with either mAb BVD4-1Dll.2 against Ib4 or mAb R46A2 against 
IFN-% In designated experiments, cells were first selected for ex- 
pression of CD4 + using magnetic beads. Serial threefold dilutions 
of cells were prepared and the plates were incubated undisturbed 
without further  stimulation for 8 h at 37~  in a 5% CO2 at- 
mosphere. Wells were washed with PBS to remove cells and fur- 
ther  incubated with biotinylated secondary antibodies, BVD6- 
24G2.3 and XMG-6, against Ib4 or IFN-% respectively.  After 1 h, 
wells were washed and 100/zl steptavidin alkaline phosphatase 
(Jackson Immuno Research Laboratories,  West Grove, PA) in PBS 
with .05% Tween 20 and 5% FBS were added for an additional 
hour. Color was developed  using 5-bromo-4-chloro-3-indolyl  phos- 
phate in 0.1 M 2-amino-2-methyl-l-propanol buffer (both from 
Sigma Chemical  Co.,  St.  Louis, MO)  suspended in  agarose 
(SeaPlaque; FMC Bioproducts, Rockland, ME) and, after solidi- 
fication of the agar, individual blue spots were counted using in- 
verted microscopy. 
Antibody Isotypes.  Total  serum IgE was quantitated using ELISA 
as described (8). Leishmania-specific  IgG isotypes were quantitated 
by incubating sera in wells that had been previously coated with 
50/~g/well soluble L. major antigen (8). After washing with PBS 
containing  0.05% Tween  20, wells  were incubated  with biotinyhted 
murine anti-Ig isotype-specific mAbs (Caltag Laboratories, San 
Francisco, CA),  washed, developed using  horseradish peroxi- 
dase-streptavidin (Zymed Laboratories, San Francisco, CA) with 
o-phenylenediamine  (Sigma Chemical Co.), and quantitated using 
a spectrophotometer. 
Results 
IFN-7  ~176  Mice Are Unable to Restrict the Progression of L. 
major Infection.  Mice with homozygous disruption of the 
IFN-3' gene on the resistant C57BL/6 background developed 
progressive infection with L. major characterized by large le- 
sions at the site of inoculation (Fig. 1) and sudden death from 
5 to 7 wk after infection. Necropsy revealed tremendous hyper- 
trophy of all LN and the spleen; cultures of lymph tissues 
and  footpads  revealed  parasites  at  substantiaUy  increased 
numbers as compared with control animals (IFN-3,~176  >10  s 
parasites per 0.1 g footpad tissue or per 5  x  106 spleen cells; 
C57BL/6 heterozygote and wild type: <102 parasites  per 
footpad tissue or spleen).  Control mice included wild-type 
C57BL/6 and heterozygous IFN-'r-ddident littermates, both 
of which were able to restrict the progression of infection. 
Disease in IPN-'y  ~176  mice was more fulminant than in sus- 
ceptible  BALB/c mice, none of which died during the first 
7 wk after infection (Fig.  1). 
CD4 + T  Cells Default  to  the  Th2  Pathway  in  IFN-7  ~176 
Mice.  CD4 § calls were purified using magnetic bead selec- 
tion from LN tissues of designated groups of mice 4 wk after 
infection. After RNA purification and reverse transcription, 
eDNA was analyzed for cytokine transcripts and standardized 
to HPRT using a competitive PCR construct (10). Hetero- 
zygous IFN-'r-deficient mice had transcripts for IFN-3, and 
lymphotoxin that were induced 7.7- and 2.1-fold, respectively, 
above those in uninfected animals (Fig. 2). Similar induction 
of the Thl transcripts occurred in infected wild-type C57BL/6 
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Figure  1.  L. major  infection  in IFN-3' knockout  mice. Groups of five 
mice were infected  in the hind footpads  with promastigotes  of L. major 
and the course of disease monitored  using metric calipers to quantitate 
the swelling  at the site of inoculation.  Infected  mice included  susceptible 
BALB/c and resistant wild-type  (C57BL/6 +/+), heterozygous  IFN-'y 
knockout mice (C57BL/6 +/-)  and  homozygous knockout mice 
(C57BL/6 -/-). Results  represent mean  and SE from  one of three repre- 
sentative experiments. 
1368  Th2 Cell Default Figure  2.  Cytokine  transcripts 
in CD4 + T ceils after infection 
with L. major. CD4 + cells were 
purified from LN from groups of 
four infected BALB/c, BALB/c 
treated with anti-Ib4, C57BL/6 
homozygous  knockout  mice  (C57 
-/-),  C57BL/6 heterozygous 
knockout mice (C57 +/-), and 
11nin~t~d C57BL/6 (na/t,e)  mice. 
RNA was purified and  reverse 
transcribed, and the cDNA used 
for PCIL-mediated amplification 
of the designated  cytokines.  Con- 
centrations of input cDNA were 
standardized by equalizing ampli- 
fication of the constitutively  expressed  HPRT transcript by use of a com- 
petitor construct containing tandemly  arrayed  amplification  products that 
are hrger and migrate more slowly  in agarose gels. After ethidium bro- 
mide staining, quantitation of  transcripts was accomplished  by comparing 
amplification of the  wild-type cDNA (lower band for  each paired 
amplification product) with the construct product (upper band for each 
paired amplification product) using imaging densitometry  of the photo- 
graphic negative. Results are representative  of three independent experi- 
ments assaying interferon-3~ (IFN-3/), lymphotoxin (LT), and IL-4, -5, 
and -13. 
mice (9; data not shown). Further, Th2 cytokine transcripts, 
including IL-4, IL-5, and IL-13, were minimally expressed 
by these cells. Susceptible BALB/c mice had detectable IFN-3, 
transcripts,  but significantly less induction of lymphotoxin 
(greater than  a twofold decrease)  and substantial induction 
of IL-4, IL-5, and IL-13.  Similarly,  IFN-'y  ~176  mice had un- 
detectable  levels  of lymphotoxin  and  substantial  levels  of 
mRNA for IL-4,  IL-5,  and IL-13,  consistent with  the ap- 
pearance  of Th2  cells. 
Two assays were performed  to confirm  that  biologically 
active IL-4 was being produced in the setting of induced IL-4 
transcripts.  First,  ELISPOT  assays,  which  detect  focused 
cytokine production by lymphocytes (13),  were carried out 
for both IL-4 and IFN-%  In these assays, lymphocytes iso- 
lated from infected mice were incubated over plates coated 
with mAb to the designated cytokine without further inter- 
vention for 8 h. After washing, cytokine trapped on the plate 
was identified using a second mAb before colorimetric de- 
velopment.  Lymphocytes producing  IFN-%  but not  IL-4, 
were readily identified from heterozygous IFN-3,-deficient 
mice, whereas the reciprocal pattern, lymphocytes producing 
IL-4 but not IFN-y, was evident in IFN-3,  ~176  mice (Fig.  3). 
The frequency of cytokine-producing cells was comparable 
in the two groups of mice. Similar results were obtained if 
CD4 + lymphocytes were first enriched using magnetic bead 
selection  before plating  in  the  ELISPOT  assay  (data  not 
shown),  consistent  with  the prior  identification  of CD4 + 
cells as the primary source of these cytokines in leishmaniasis 
(9).  Lymphocytes from  uninfected  animals  that  generated 
IFN-? or IL-4 were <8 and 1%, respectively, than the number 
recovered from infected mice. Second, antibody isotypes were 
quantitated in serum from infected mice as an indirect mea- 
sure of the ability of IL-4 to promote IgG1 and IgE and of 
IFN-3'  to  promote  IgG2a  and  IgG3  (14).  As  anticipated, 
Figure 3.  Cytokine produc- 
tion by LN cells after infection 
with L. major. Popliteal  LN cells 
draining the site  of  infection  were 
incubated  over  wells  that had been 
precoated with  mAbs against 
IFN-3, (top)  or Ib4 (bottom). Cells 
were  diluted  threefold  in duplicate 
from the top to the bottom  of  each 
panel. After undisturbed incuba- 
tion for 8 h, cells were washed 
away and the captured cytokine 
developed using a second mAb 
and colorimetric reagent in agar. 
(C57 -/- ) Cells  from a homozy- 
gous  knockout mouse; (C57 
+/- ) ceUs  from a heterozygous 
littermate. Results represent one 
of two comparable  experiments. 
IFN-3  ,~176  mice had substantially lower levels of IgG2a and 
IgG3,  and,  consistent  with  the  in  vivo  activation  of IL- 
4-producing cells, enhanced levels of IgG1 and IgE, as com- 
pared with  phenotypically resistant  animals  (Fig.  4). 
Discussion 
The development of Thl and Th2 cells from naive precursors 
is of much interest  in understanding  the nature of the im- 
mune response, including determinants  of disease suscepti- 
bility and the evaluation of vaccines.  IL-4 has been demon- 
strated to enhance Th2 development in vitro (3, 4,  15) and 
in vivo (15),  and mice with homologous disruption  of the 
IL-4 gene have impaired  ability to generate Th2  responses 
(6).  Conversely,  IL-12,  a heterodimeric  cytokine produced 
by macrophages (and B cell lines) (16), has been demonstrated 
to induce Thl call responses in several in vitro systems (17, 
18).  IL-12 induces the production  of IFN-3~ from both T 
lymphocytes and NK cells. It is also a growth factor for acti- 
vated T calls and promotes the development of Thl effector 
cells. It is unclear whether the Thl-promoting  effects of IL- 
12 are indirectly mediated by IFN-% however. Evidence sug- 
gests that  IFN-qr cannot itsdf prime for Thl  ceU develop- 
ment in vitro (4, 19) and cannot mediate sustained Thl ceU 
development in vivo in  the L.  major system in  susceptible 
BALB/c mice (8). Conflicting results have been described for 
the capacity of anti-IFN-3, to abrogate Thl cell development 
in vitro (18-20), although anti-IFN-3, can ablate the ability 
of genetically  resistant  mice  to  control  infection  due  to 
L.  major (21).  Detailed evaluation of the latter  mice,  how- 
ever, has not been reported to suggest whether default occurs 
into the Th2 pathway. The experiments detailed here further 
establish  the  requirement  for  IFN-3~  in  the  control  of 
Leishmania. 
The L. major system provides a mechanism for providing 
antigens that normally trigger Thl cell development to animals 
deficient in IFN-3,. If genetic resistance alone constituted the 
basis for the Thl/Th2  switch in CD4 + T  cells, the expected 
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Figure 4.  Antibody isotypes after infection with L. major. 
Groups of designated mice were infected with L. major for 
5 wk and senun prepared for analysis. Uninfected wild-type 
C57BL/6 are shown for comparison (C57BL/6 naive). IgG 
isotypes and lgM were measured by incubating serum over 
wells precoated with L. major antigens,  washing, and quan- 
titating the captured antibody using an isotype-specific mAb 
and colorimetric development.  Results are expressed as mean 
+/-  SEM of the optical density units (O/~). Total IgE was 
quantitated using a double mAb antibody-based sandwich 
ELISA and is expr~sed as mean •  SEM/~g/ml as determined 
using a standardized control. Lewis of IgE were not different 
between uninfected C57BL/6 heterozygous and homozygous 
knockout mice (<1/zg/ml in both). 
result would have been CD4 + T cells containing transcripts 
for lymphotoxin, but not the Th2-type transcripts, II.4, IL-5, 
and  IL-13. In  contrast,  these  mice uniformly developed 
CD4 ~ T  cells containing low levels of lymphotoxin and 
high levels of Th2-type transcripts, consistent with default 
of these cells into a Th2 effector pathway. Although either 
outcome would be predicted to lead to failure to control dis- 
ease due to the absence of the macrophage-activating capacity 
of IFN-% the mRNA and ELISPOT studies readily demon- 
strated the differences in CD4 + subset differentiation.  The 
methods used required minimal manipulation of tissues in 
vitro, such as restimulation with antigens or mitogens, and 
accurately  reflected  the antibody isotypes quantitated in serum. 
Taken together, the results are consistent with the interpre- 
tation that, at least for this well-characterized system, IFN-3~ 
is required for the development of Thl cells in vivo. The pos- 
sibility that IFN-'y derived from NK cells might play a role 
in Thl cell differentiation in the response to L. major  has been 
suggested (22), and would be consistent with the results ob- 
tained here. Challenge of these mice or mice deficient in the 
IFN-'y receptor with additional organisms, including L/ster/a 
and mycobacteria, also demonstrated inability to control in- 
fection, although detailed analysis of the immune response 
was not reported (7, 23,  24). 
The mechanism by which naive T  cells default into the 
Th2 pathway may reflect the occurrence of unopposed IL-4 
generation at the time of T cell activation by antigen.  The 
addition of I1.-4 during priming constitutes a strong stimulus 
for development of Th2 cells (3, 4),  and neutralization  of 
even the small amounts of IL-4 generated during the initial 
activation of  naive cells results in default into the Thl pathway 
(3). The recent report that IL-4 suppresses IL-2 and IFN-'y 
production by naive cells during their initial activation by 
APCs (25) suggests that unopposed IL4 would be detrimental 
for diseases requiring Thl responses, like leishmaniasis. Fi- 
naUy, IFN-3, itself  can inhibit proliferation of Th2 cells (26), 
and loss of this cytokine would be expected to favor sustained 
expansion of this population.  It seems unlikely that these 
results reflect outgrowth of a small population  of cells re- 
sponding to a unique antigen, however, in view of the exten- 
sive analysis of the CD4 + cell response in these mice, sug- 
gesting that Thl and Th2 cells arise from common precursors 
(27). Such findings are in agreement with studies using cells 
from TCR transgenic mice demonstrating the capacity to 
drive these cells to both the Thl and Th2 phenotypes (3, 
4). The data presented suggest an important role for IFN-y 
in Thl development in vivo and emphasize the useful role 
genetically modified mice play in elucidating critical factors 
involved in the immune response to infectious organisms. 
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